Efavirenz group (N = 65) | Nevirapine group (N = 59) | |||||||
---|---|---|---|---|---|---|---|---|
CYP2B6 -G516T | CYP2B6 -G516T | |||||||
GG
n = 25 |
GT
n = 31 |
TT
n = 9 | p-value* |
GG
n = 26 |
GT
n = 31 |
TT
n = 2 | p-value** | |
No. of patients (%) |
17 (68) |
24 (77.42) |
8 (88.89) | 0.430 |
15 (60) |
23 (70.97) |
2 (100) | 0.288 |